Wells Fargo Maintains Overweight on Johnson & Johnson, Raises Price Target to $263

Wells Fargo analyst Larry Biegelsen maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and raises the price target from $240 to $263.